Action PSTX POSEIDA THERAPEUTICS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Poseida Therapeutics, Inc.

Actions

PSTX

US73730P1084

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 31/05/2024 		Varia. 5j. Varia. 1 janv.
2,99 USD +3,10 % Graphique intraday de Poseida Therapeutics, Inc. +0,67 % -11,01 %
14/05 Poseida Therapeutics réduit sa perte nette au premier trimestre et augmente son chiffre d'affaires MT
14/05 Poseida Therapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell Therapy 27th Annual Meeting
AQ
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
PR
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
PR
Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
AQ
Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
PR
Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PR
Poseida Therapeutics to Present at H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
PR
Poseida Therapeutics : Provides Updates and Financial Results for the Fourth Quarter and Full Year 2023 - Form 8-K
PU
Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PR
Poseida Therapeutics to Present at Two Upcoming Investor Conferences
PR
Poseida Therapeutics to Present at the 65th ASH Annual Meeting and Exposition
AQ
Poseida Therapeutics Announces Leadership Transition
PR
Poseida Therapeutics to Present at Two Upcoming Investor Conferences
PR
Poseida Therapeutics Announces Strategic Investment by Astellas and Provides Business Update
AQ
Poseida Therapeutics to Join Russell 3000 and Russell 2000 Indexes
AQ
Poseida Therapeutics to Join Russell 3000® and Russell 2000® Indexes
PR
POSEIDA THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
POSEIDA THERAPEUTICS, INC. : Termination of a Material Definitive Agreement, Other Events (form 8-K)
AQ
Poseida Therapeutics Announces Virtual 2023 Annual Meeting of Stockholders
PR
Poseida Therapeutics to Present at Stifel 2023 Tailoring Genes, Genetic Medicines Day
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PSTX
  4. Actualités Poseida Therapeutics, Inc.
  5. Communiqués
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT